Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tilray Brands Inc (NQ: TLRY )

1.340 +0.030 (+2.29%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tilray Brands Inc

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Meta Faces Multibillion-Dollar Lawsuit As Supreme Court Dismisses Appeal In Cambridge Analytica Data Scandal
Meta Platforms faces a multibillion-dollar lawsuit after the U.S. Supreme Court dismissed its appeal over the Cambridge Analytica data scandal, potentially leading to a $2 billion settlement. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
420 with CNW — New Study Explores the Health Conditions for Which Individuals Use Medical Cannabis
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
German Cannabis: 20 Tons, 10M Grams - And That's Only 0.3% Of The Market, What's Missing?
Medical cannabis users still represent less than 0.3% of the population, indicating significant potential for market expansion. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56. 
Via Benzinga
Topics Cannabis ETFs Government
Exposures Cannabis Political
Redhook Brewery and Montlake Futures Team Up to Launch Montlake Gameday Gold Lager, a New Craft Beer in Support of University of Washington Athletes
From Tilray Brands, Inc.
Via GlobeNewswire
Tilray Brands Unveils 2024 Holiday Cannabis Gift Guide
Indulge in Premium Chocolate Edibles, Cannabis-Infused Drinks, New Pre-Rolls, and Top-Quality Flower - the Perfect Selection for Cannabis Connoisseurs this Festive Season! 
From Tilray Brands, Inc.
Via GlobeNewswire
Tilray Brands Gets Festive with its 2024 Holiday Beverage Gift Guide
From Tilray Brands, Inc.
Via GlobeNewswire
Prediction: Tilray Brands Won't Be a Cannabis Company in 5 Years
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
How Is The Market Feeling About Tilray Brands?
Via Benzinga
These 2 Marijuana Stocks Could Surge Under Trump's Second Term
Via The Motley Fool
Topics Cannabis Government
Exposures Cannabis Political
Beverages, Alcohol and Tobacco Stocks Q3 Recap: Benchmarking Tilray Brands (NASDAQ:TLRY)
Looking back on beverages, alcohol and tobacco stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Tilray Brands (NASDAQ:TLRY) and its peers. 
Via StockStory
Topics Cannabis
Exposures Cannabis
Q3 Earnings Outperformers: Celsius (NASDAQ:CELH) And The Rest Of The Beverages, Alcohol and Tobacco Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Celsius (NASDAQ:CELH) and the best and worst... 
Via StockStory
Topics Cannabis
Exposures Cannabis
Shareholder Lawsuit Challenges Tilray's Voting Tactics For Authorized Share Increase
Tilray faces a new shareholder lawsuit accusing the company of misleading voting practices, following a $39.9M settlement over similar issues 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Tilray Joins German Cannabis Fiesta With First Locally Grown Strains
Tilray Medical launches its first German-grown cannabis products under a new cultivation license, tapping into Germany's expanding market... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
CBD Pioneer Charlotte's Web Narrows Loss In Q3, Focuses On Long-Term Growth
Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF) a producer of hemp-derived CBD and other botanical wellness products, reported on Thursday financial results for the third quarter ended Sept.... 
Via Benzinga
Blue Point Brewery Expands Winter Seasonal Lineup with Blitz Beer American Lager and Hosts The Blue Point Blitz Celebration at Webster Hall
From Tilray Brands, Inc.
Via GlobeNewswire
Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License
From Tilray Brands, Inc.
Via GlobeNewswire
Get Ready for Winter with 10 Barrel’s 13th Annual Pray for Snow Party
Join 10 Barrel Brewing for a Free Community Event Celebrating the Snowboard Season with Live Music, Giveaways, and the Premiere of the "Beer Lodge" film at 10 Barrel’s Winter Party 
From Tilray Brands, Inc.
Via GlobeNewswire
Breckenridge Distillery's Latest Creation is the Perfect Addition to Your Holiday Bar: Breckenridge Candy Cane Vodka
From Tilray Brands, Inc.
Via GlobeNewswire
Does the Rejection of Top Marijuana Legalization Measures Doom the Pot Industry?
The American electorate seems to have turned against weed legal reform. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
420 with CNW — German Marijuana Club Hands Out Legal Cannabis as Pilot Program Kicks Off
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Pop Following Chris Christie's Prediction That Trump Will Deschedule Cannabis
Cannabis stocks rally on prediction of Trump descheduling marijuana; MSOS leads gains with a 15% surge, followed by Cronos at nearly 13%. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Experience the Ultimate 420 Festival Celebration with SweetWater's 20th Anniversary Lineup Featuring The Revivalists, Marcus King Band, Greensky Bluegrass, Drive-By Truckers and Cypress Hill at Atlanta's Iconic Pullman Yards from April 18-20, 2025
From Tilray Brands, Inc.
Via GlobeNewswire
Cannabis Stocks: Is It Time To Buy The Dip After Elections And Legalization Setbacks?
After a post-election plunge, cannabis stocks are showing signs of recovery. We analyze Tilray, SNDL, Trulieve, MSOS – time to buy the dip? 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Aurora vs. Canopy & Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?
Aurora's international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Extract Significantly Reduces Chemotherapy-Induced Vomiting, Tilray-Backed Study Reveals
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Launches "Men's Health on Tap" Podcast: Acclaimed Doctors Engage in Empowering Discussions and Break Down Stigmas Around Men's Health Topics
From Tilray Brands, Inc.
Via GlobeNewswire
Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis
From Tilray Brands, Inc.
Via GlobeNewswire
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
Following Trump's presidential election victory, the cannabis sector took a sharp downturn. Here's a summary of what happened today. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Tilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty
Cannabis stocks plunge as Florida's legalization fails and GOP Senate control tempers expectations for industry growth. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.